| Up
2005D-0261:
Guidance for Industry: Nucleic Acid Testing (NAT) for Human Immunodeficiency
Virus Type 1 (HIV-1) and Hepatitis C Virus (HCV): Testing, Product
Disposition, and Donor Deferral and Reentry
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| GDL1
|
| 07/26/2005
|
| 07/26/2005
|
| Federal
Government
|
| Guideline
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
| Signature:
|
| Guideline
|
|
|
|
|
|
|
|
| NAD1
|
|
|
| 07/26/2005
|
| FDA
|
| FDA
|
| 07/27/2005
|
| 43439-43440
|
| 10/25/2005
|
| pdf
|
|
|
|
|
| Signature:
|
| JEFFREY SHUREN
|
|
|
|
|
| BKG1
|
| 07/26/2005
|
| 07/26/2005
|
| Federal
Government
|
| Tabs 1 - 13
|
|
|
|
|
|
|
| Table
of Contents
|
|
|
|
|
|
|
|
|
| Signature:
|
| Tabs 1 - 13
|
|
|
|
|
| EC1
|
| 08/01/2005
|
| 07/29/2005
|
| Drug Industry
|
| BloodSource
|
|
|
|
|
|
|
| htm
|
|
|
|
|
|
|
| Signature:
|
| Padilla, Erica
| |
Top | Up
Page last updated
August 18, 2005
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |
